CELZ — CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

—
Nasdaq · Health Care · Biotechnology · CIK 1187953 ·
Last close
$0.48
Market Cap
$3.62M
52W High
$4.72
52W Low
$0.46
ADV30
101,713
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 0 -2,725,952 -2,670,076 7,278,806 6,845,741 293,226
Jun 2026 0 0 -1,562,163 -1,511,976 9,377,653 8,714,115 698,595
Mar 2026 0 0 -1,459,153 -1,405,077 6,440,577 5,723,176 307,649
Dec 2025 3,000 2,006 -1,945,782 -1,887,674 7,809,525 7,208,126 284,880

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,901,718
Investing CF
$-225,500
Financing CF
$8,297,213
CapEx
$-125,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.75
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-73,503,974
Inventory
$0
Receivables
$109,338
ST Investments
$125,000
EBIT TTM
$-6,240,132
Pretax Income TTM
$-6,038,575
Interest Exp TTM
—
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,000
EBITDA
$-6,126,351
Free Cash Flow
$-3,456,562
Enterprise Value
$-4,700,264
Total Cash
$8,839,115
Total Debt
$14,194
Shares Out
7,592,557
Trailing EPS
$-2.07
Book Value
$2.03
ROE
-77.9%
ROA
-47.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 6,000 -6,142,814 -5,995,008 7,809,525 284,880 7,514,645 -5,856,445
Dec 2024 11,000 -5,743,861 -5,493,481 6,669,143 327,644 6,341,499 -5,301,292
Dec 2023 9,000 -5,620,132 -5,286,574 10,715,190 371,394 10,343,796 -8,027,885
Dec 2022 88,600 -10,244,372 -10,144,044 19,186,326 3,321,652 15,864,674 -7,796,966

TTM Snapshot

Revenues TTM
$3,000
NetIncome TTM
$-6,040,661
OpCashFlow TTM
—
Assets (Latest)
$9,377,653
Forward EPS
$-0.88

Peers — same industry

TickerNameMarket CapLastDaily %
CRIS CURIS INC $3.62M $0.54 —
LIMN Liminatus Pharma, Inc. $3.77M $2.81 —
SNTI Senti Biosciences Holdings, Inc. $3.02M $0.10 —
BCAB BioAtla, Inc. $3.00M $1.80 —
SCLX Scilex Holding Co $4.52M $0.64 —

News headlines (Yahoo Finance, 1h cache)

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
2026-10-20 13:15 · Yahoo
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
2026-09-17 13:00 · Yahoo
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluat
2026-08-20 13:15 · Yahoo
Creative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy
2026-08-06 15:04 · Yahoo
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CEL
2026-08-06 13:15 · Yahoo
Creative Medical Technology Holdings Issues Mid-Year Update
2026-07-01 13:00 · Yahoo
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
2026-06-30 18:07 · Yahoo
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism?
2026-06-26 17:54 · Yahoo
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
2026-06-22 13:15 · Yahoo
Creative Medical Technology opens nationwide burn-pit data registry
2026-06-16 19:49 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.